DOFI
DCVC Opportunity Fund II’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20M | Hold |
3,951,141
| – | – | 17.35% | 2 |
|
|
2025
Q1 | $20.9M | Hold |
3,951,141
| – | – | 25.65% | 2 |
|
|
2024
Q4 | $26.7M | Hold |
3,951,141
| – | – | 23.64% | 2 |
|
|
2024
Q3 | $26M | Hold |
3,951,141
| – | – | 26.74% | 2 |
|
|
2024
Q2 | $29.6M | Hold |
3,951,141
| – | – | 44.95% | 2 |
|
|
2024
Q1 | $39.4M | Hold |
3,951,141
| – | – | 55.14% | 1 |
|
|
2023
Q4 | $39M | Buy |
+3,951,141
| New | +$39M | 48.18% | 2 |
|
|
2022
Q3 | $42M | Hold |
3,951,141
| – | – | 54.37% | 1 |
|
|
2022
Q2 | $32.2M | Hold |
3,951,141
| – | – | 47.32% | 1 |
|
|
2022
Q1 | $28.3M | Hold |
3,951,141
| – | – | 31.54% | 2 |
|
|
2021
Q4 | $67.7M | Buy |
+3,951,141
| New | +$67.7M | 33.92% | 2 |
|